Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | FUENZALIDA, HECTOR |
| Género | Hombre |
| Área Principal WOS | Dermatology; |
| Afiliación Principal | Universidad De Santiago De Chile |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| Año | Firma | Institución (Incites asoc.) | H Index | Average Percentile | Impact Citation | Impact Relative World | Impact Journal Normalized Citation | Impact Category Normalized Citation | Percentage Cited | Percentage Top 1 | Percentage Top 10 | Percentage Journal Q1 | Percentage Journal Q2 | Percentage Journal Q3 | Percentage Journal Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | Fuenzalida, Hector | Universidad de Chile | 2.0 | 69.9 | 4.5 | 0.5 | 0.4 | 0.3 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 |
| 2019 | Fuenzalida, H. | Universidad de Chile | 1.0 | 80.8 | 1.0 | 0.1 | 0.3 | 0.2 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 |
| 2019 | Fuenzalida, Hector | Universidad de Santiago de Chile | 1.0 | 57.5 | 7.0 | 0.8 | 0.6 | 0.5 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Palabra Clave | #Pub |
|---|---|
| diagnosis | 2 |
| information systems | 1 |
| treatment | 1 |
| teledermatology | 1 |
| syndrome | 1 |
| signs and symptoms | 1 |
| seguridad | 1 |
| safety | 1 |
| reticulate lesions | 1 |
| quality of care | 1 |
| quality | 1 |
| oral isotretinoin | 1 |
| nummular eczema | 1 |
| nummular dermatitis | 1 |
| multiple glomus tumors | 1 |
| methotrexate | 1 |
| malformations | 1 |
| acne | 1 |
| imiquimod | 1 |
| historical-perspective | 1 |
| hand | 1 |
| gel-cream | 1 |
| forward teledermatology | 1 |
| feedback systems | 1 |
| emollients | 1 |
| emerging techniques | 1 |
| effectiveness | 1 |
| efectividad | 1 |
| discoid eczema | 1 |
| benign | 1 |
| adjuvant treatment | 1 |